Reasons why access cannot be provided (enquiries for Novartis studies)

Reason Number of studies
Out of scope - ongoing related extension studies 1
Out of scope - Phase 1 study 106
Out of scope – Phase 4 study 7
Out of scope - study still ongoing 18
Out of scope - unapproved indication 8
Out of scope - risk of reidentification due to small number of patients 3
Out of scope - Could not identify study with information provided 2
Out of scope - Asset divested to another company 24
Data too old; not compatible with current anonymization applications 2
Novartis is not the sponsor of the requested study 2